Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) Return on Capital Employed (2024 - 2025)

Zenas BioPharma has reported Return on Capital Employed over the past 2 years, most recently at 0.27% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.27% for Q4 2025, up 22.0% from a year ago — trailing twelve months through Dec 2025 was 0.27% (up 22.0% YoY), and the annual figure for FY2025 was 0.25%, up 76.0%.
  • Return on Capital Employed for Q4 2025 was 0.27% at Zenas BioPharma, up from 0.79% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ZBIO hit a ceiling of 0.27% in Q4 2025 and a floor of 0.79% in Q3 2025.